Pfizer-BioNTech Covid-19 vaccine found effective in kids aged five to 11 years: Study

By NS Healthcare Staff Writer

21 Sep 21

In the trial, Comirnaty showed a neutralising antibody geometric mean titre (GMT) of 1,197.6 in children aged five…

PharmaceuticalsClinical trials

J&J’s Ebola vaccine regimen effective in adults and children, shows Phase 3 data

By NS Healthcare Staff Writer

14 Sep 21

The data was based on Phase 3 EBOVAC-Salone clinical study, in which the vaccine regimen was well-tolerated in…

PharmaceuticalsClinical trials

Biological E gets DCGI nod to study Covid-19 vaccine in children, adolescents

By NS Healthcare Staff Writer

06 Sep 21

Biological E developed Corbevax in partnership with Baylor College of Medicine and biopharmaceutical company Dynavax Technologies

PharmaceuticalsClinical trials

SK, GSK partner to study adjuvanted Covid-19 vaccine candidate

By NS Healthcare Staff Writer

01 Sep 21

The Phase 3 clinical trial will evaluate SK’s vaccine candidate GBP510 against the AstraZeneca/Oxford Covid-19 vaccine

PharmaceuticalsClinical trials

Moderna’s Covid-19 shot effective against SARS-CoV-2 variants, says study

By NS Healthcare Staff Writer

13 Aug 21

The majority of people vaccinated with Moderna’s vaccine maintained both binding and functional antibodies against SARS-CoV-2 variants

PharmaceuticalsClinical trials

Roche’s Polivy combination study shows positive outcomes in treating DLBCL

By NS Healthcare Staff Writer

10 Aug 21

The Phase 3 trial evaluated the efficacy, safety and pharmacokinetics of Polivy in combination with R-CHP, compared to…

PharmaceuticalsClinical trials

Pfizer’s Phase 2b/3 ritlecitinib trial meets primary endpoint

By NS Healthcare Staff Writer

05 Aug 21

The randomised, placebo-controlled, double-blind Phase 2b/3 ALLEGRO trial met the primary efficacy endpoint of improving scalp hair regrowth,…

PharmaceuticalsClinical trials

J&J’s single-shot Covid-19 vaccine shows promise against Delta variant

By NS Healthcare Staff Writer

05 Jul 21

The data included new analysis from blood samples obtained from a subset of participants in the Phase 3…

PharmaceuticalsClinical trials

Starpharma’s Viraleze nasal spray effective against multiple Covid-19 variants

By NS Healthcare Staff Writer

21 Jun 21

Starpharma claims that its Viraleze is the only nasal spray to show more than 99.9% antiviral activity against…

PharmaceuticalsClinical trials

Sage, Biogen’s MDD drug Zuranolone meets primary endpoint in Phase 3 trial

By NS Healthcare Staff Writer

16 Jun 21

Sage and Biogen claimed that their investigational drug Zuranolone is a potential breakthrough in the management of depression

PharmaceuticalsClinical trials